Actively Recruiting
Preserving Laryngeal Function Using Toripalimab with Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
Led by Matthew Spector · Updated on 2026-10-16
87
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the safety, tolerability, and disease survival rates in adults with recurrent or metastatic head and neck squamous cell carcinoma HNSCC, specifically focusing on locally advanced laryngeal or hypopharyngeal squamous cell carcinoma. The study addresses concerns about the morbidity of total laryngectomy surgery and explores a novel approach using neoadjuvant chemoimmunotherapy to potentially preserve laryngeal function and improve survival outcomes. Participants receive an induction regimen of toripalimab combined with carboplatin or cisplatin and paclitaxel administered intravenously every three weeks for two cycles. After this induction, patients undergo re-evaluation with laryngoscopy, imaging, and swallowing function assessments. Based on their response and disease status, they may continue treatment with chemoradiation plus toripalimab or radiation plus toripalimab monotherapy, followed by toripalimab alone for up to eight cycles. Throughout the study, participants are monitored using laryngoscopy, imaging, and assessments of swallowing function and extranodal extension status. Outcome measures include one-year disease-free survival, overall survival up to five years, larynx preservation rates, and swallowing impairment prevalence at multiple timepoints. The study also tracks neck dissection impairment throughout treatment. Participation may last several years, with long-term follow-up to evaluate these outcomes.
CONDITIONS
Brief Title
Window of Opportunity in Preserving Laryngeal Function Trial
Research Team
J
Jennifer Ruth, RN, BSN, CCRP
M
Mel J Mendez, BS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here